PLAUR and neoplasm: Based on the high expression of uPAR on the surface of tumour cells, some researchers have explored the combination of CAR T-cell immunotherapy and uPAR targeting to treat uPAR-expressing malignancies or the use of uPAR as a target to induce immune-mediated clearance of uPAR-positive tumour cells by constructing ARMs.